BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

280 related articles for article (PubMed ID: 21232964)

  • 21. Novel structural hybrids of pyrazolobenzothiazines with benzimidazoles as cholinesterase inhibitors.
    Aslam S; Zaib S; Ahmad M; Gardiner JM; Ahmad A; Hameed A; Furtmann N; Gütschow M; Bajorath J; Iqbal J
    Eur J Med Chem; 2014 May; 78():106-17. PubMed ID: 24681070
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Triterpene-Based Carboxamides Act as Good Inhibitors of Butyrylcholinesterase.
    Loesche A; Kahnt M; Serbian I; Brandt W; Csuk R
    Molecules; 2019 Mar; 24(5):. PubMed ID: 30866589
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis of some new 3-coumaranone and coumarin derivatives as dual inhibitors of acetyl- and butyrylcholinesterase.
    Alipour M; Khoobi M; Nadri H; Sakhteman A; Moradi A; Ghandi M; Foroumadi A; Shafiee A
    Arch Pharm (Weinheim); 2013 Aug; 346(8):577-87. PubMed ID: 23852709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 2-(2-indolyl-)-4(3H)-quinazolines derivates as new inhibitors of AChE: design, synthesis, biological evaluation and molecular modelling.
    Li Z; Wang B; Hou JQ; Huang SL; Ou TM; Tan JH; An LK; Li D; Gu LQ; Huang ZS
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):583-92. PubMed ID: 22380775
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 1,2,3,4-Tetrahydrobenzo[h][1,6]naphthyridines as a new family of potent peripheral-to-midgorge-site inhibitors of acetylcholinesterase: synthesis, pharmacological evaluation and mechanistic studies.
    Di Pietro O; Viayna E; Vicente-García E; Bartolini M; Ramón R; Juárez-Jiménez J; Clos MV; Pérez B; Andrisano V; Luque FJ; Lavilla R; Muñoz-Torrero D
    Eur J Med Chem; 2014 Feb; 73():141-52. PubMed ID: 24389509
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In silico, theoretical biointerface analysis and in vitro kinetic analysis of amine compounds interaction with acetylcholinesterase and butyrylcholinesterase.
    Kandasamy S; Loganathan C; Sakayanathan P; Karthikeyan S; Stephen AD; Marimuthu DK; Ravichandran S; Sivalingam V; Thayumanavan P
    Int J Biol Macromol; 2021 Aug; 185():750-760. PubMed ID: 34216669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Design, synthesis and cholinesterase inhibitory activity of quinoline-polyamine conjugates].
    Luo W; Huang K; Zhang Z; Hong C; Wang CJ
    Yao Xue Xue Bao; 2013 Feb; 48(2):269-75. PubMed ID: 23672025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of physostigmine analogues and evaluation of their anticholinesterase activities.
    Zhan ZJ; Bian HL; Wang JW; Shan WG
    Bioorg Med Chem Lett; 2010 Mar; 20(5):1532-4. PubMed ID: 20144867
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of a neuroprotective and selective butyrylcholinesterase inhibitor derived from the natural alkaloid evodiamine.
    Huang G; Kling B; Darras FH; Heilmann J; Decker M
    Eur J Med Chem; 2014 Jun; 81():15-21. PubMed ID: 24819955
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and synthesis of N-substituted-2-hydroxyiminoacetamides and interactions with cholinesterases.
    Maraković N; Knežević A; Vinković V; Kovarik Z; Šinko G
    Chem Biol Interact; 2016 Nov; 259(Pt B):122-132. PubMed ID: 27238725
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Exploiting protein fluctuations at the active-site gorge of human cholinesterases: further optimization of the design strategy to develop extremely potent inhibitors.
    Butini S; Campiani G; Borriello M; Gemma S; Panico A; Persico M; Catalanotti B; Ros S; Brindisi M; Agnusdei M; Fiorini I; Nacci V; Novellino E; Belinskaya T; Saxena A; Fattorusso C
    J Med Chem; 2008 Jun; 51(11):3154-70. PubMed ID: 18479118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inhibition of two different cholinesterases by tacrine.
    Ahmed M; Rocha JB; Corrêa M; Mazzanti CM; Zanin RF; Morsch AL; Morsch VM; Schetinger MR
    Chem Biol Interact; 2006 Aug; 162(2):165-71. PubMed ID: 16860785
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Structural modifications of 4-aryl-4-oxo-2-aminylbutanamides and their acetyl- and butyrylcholinesterase inhibitory activity. Investigation of AChE-ligand interactions by docking calculations and molecular dynamics simulations.
    Vitorović-Todorović MD; Koukoulitsa C; Juranić IO; Mandić LM; Drakulić BJ
    Eur J Med Chem; 2014 Jun; 81():158-75. PubMed ID: 24836068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Design, synthesis, docking study and biological evaluation of some novel tetrahydrochromeno [3',4':5,6]pyrano[2,3-b]quinolin-6(7H)-one derivatives against acetyl- and butyrylcholinesterase.
    Khoobi M; Alipour M; Moradi A; Sakhteman A; Nadri H; Razavi SF; Ghandi M; Foroumadi A; Shafiee A
    Eur J Med Chem; 2013 Oct; 68():291-300. PubMed ID: 23988412
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oxidation at C-16 enhances butyrylcholinesterase inhibition in lupane triterpenoids.
    Castro MJ; Richmond V; Faraoni MB; Murray AP
    Bioorg Chem; 2018 Sep; 79():301-309. PubMed ID: 29793143
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction study of two diterpenes, cryptotanshinone and dihydrotanshinone, to human acetylcholinesterase and butyrylcholinesterase by molecular docking and kinetic analysis.
    Wong KK; Ngo JC; Liu S; Lin HQ; Hu C; Shaw PC; Wan DC
    Chem Biol Interact; 2010 Sep; 187(1-3):335-9. PubMed ID: 20350537
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New data on the structure of the acyl pocket in cholinesterases.
    Moralev SN
    Dokl Biochem; 2000; 375():215-7. PubMed ID: 11296473
    [No Abstract]   [Full Text] [Related]  

  • 38. Synthesis, biological activity, and docking studies of new acetylcholinesterase inhibitors of the bispyridinium type.
    Kapková P; Stiefl N; Sürig U; Engels B; Baumann K; Holzgrabe U
    Arch Pharm (Weinheim); 2003 Nov; 336(11):523-40. PubMed ID: 14639745
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design, synthesis, and biological evaluation of coumarin derivatives tethered to an edrophonium-like fragment as highly potent and selective dual binding site acetylcholinesterase inhibitors.
    Pisani L; Catto M; Giangreco I; Leonetti F; Nicolotti O; Stefanachi A; Cellamare S; Carotti A
    ChemMedChem; 2010 Sep; 5(9):1616-30. PubMed ID: 20677317
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis and biological evaluation of a new series of berberine derivatives as dual inhibitors of acetylcholinesterase and butyrylcholinesterase.
    Huang L; Luo Z; He F; Lu J; Li X
    Bioorg Med Chem; 2010 Jun; 18(12):4475-84. PubMed ID: 20471843
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.